PH: Analysis & Opinions

  1. BorgWarner Still In A Long-Term Growth Lane

    May 13, 2013
    BorgWarner has intriguing growth prospects, but the shares have already recovered quite a bit of ground.
  2. It Should Be Up From Here For Eaton

    May 13, 2013
    Eaton should see very solid growth from here, but the market is already expecting quite a bit of that.
  3. Recent Financials May Not Be Entirely Fair To Hologic

    May 08, 2013
    Macro pressures are outweighing solid internal progress at Hologic.
  4. Hope Seems To Outshine Reality At Acuity Brands

    April 03, 2013
    Acuity's near a 52-week high, but expectations seem high relative to margin and ROIC prospects.
  5. Aixtron Is A Volatile Way To Play LED Growth

    February 15, 2013
    Aixtron will benefit from a surge in LED lighting, but it isn't known when that will happen.
  6. Data on Peregrine's Bavituximab - Analyst Blog

    February 14, 2013
    Peregrine Pharmaceuticals (PPHM) recently announced phase II data on its oncology candidate, bavituximab. The ...
  7. Enphase System at Arizona Solar Farm - Analyst Blog

    February 13, 2013
    Enphase Energy Inc. (ENPH) has announced that Arizona based Cambio Energy has completed a solar installation at the ...
  8. Priority FDA Review for Celgene Drug - Analyst Blog

    February 12, 2013
    Recently, Celgene Corporation (CELG) announced that the US Food and Drug Administration (FDA) will review the ...
  9. Still Neutral on Cepheid - Analyst Blog

    February 12, 2013
    On Feb 5, 2013, we reaffirmed our Neutral recommendation on Cepheid Inc (CPHD) following the fourth quarter 2012 ...
  10. KB Home Remains Neutral - Analyst Blog

    February 12, 2013
    We maintain a Neutral rating on KB Home (KBH) following appraisal of the second quarter 2012 results. KB Home's ...
  11. Playing Blue Gold's Rise

    February 12, 2013
    While natural resource investing has exploded in recent years, many portfolios have little to no exposure to water. ...
  12. A Relative Price Strength Screen for Beating the Market ...

    February 12, 2013
    Kevin Matras goes over a Relative Price Change screen to help you find top performers no matter what the market is ...
  13. Gilead Closes YM Biosciences Buyout - Analyst Blog

    February 11, 2013
    Recently, Gilead Sciences, Inc. (GILD) completed its acquisition of Canada-based drug development company, YM ...
  14. Regal Beloit Buys RAM Motor Business - Analyst Blog

    February 11, 2013
    Regal Beloit Corporation (RBC) recently completed the acquisition of the RAM motor business from Schneider Electric ...
  15. Protalix Exploring Options - Analyst Blog

    February 07, 2013
    Protalix BioTherapeutics, Inc. (PLX) recently confirmed that it has hired Citigroup, Inc. C) to explore strategic ...
  16. Pipeline Setback for Idenix - Analyst Blog

    February 07, 2013
    Idenix Pharmaceuticals, Inc. (IDIX) recently announced that the company has decided to discontinue its clinical ...
  17. Medivation's Xtandi Impresses - Analyst Blog

    February 07, 2013
    Medivation, Inc. (MDVN) recently announced that its partner Astellas Pharma Inc. (ALPMY) reported Xtandi ...
  18. Vivus Unveils Qsymia Study Results - Analyst Blog

    February 07, 2013
    Vivus Inc. (VVUS) recently announced the publication of results from a study regarding its weight-loss drug, Qsymia. ...
  19. Eaton Beats Revs, Guides Well - Analyst Blog

    February 05, 2013
    Industrial manufacturer Eaton Corporation (ETN) released its fourth quarter results with earnings per share of 96 ...
  20. Regal Beloit Beats Estimate - Analyst Blog

    February 05, 2013
    Regal Beloit Corporation (RBC) reported fourth quarter 2012 earnings of 70 cents per share compared to 80 cents in ...
Marketplace
Trading Center